- Novel device option in the treatment of Alzheimer's disease.
- Minimally-invasive – no implantable devices or surgeries needed.
- Reduced probability of complications and minimal side effects for patients versus implantable deep brain stimulation procedures.
- Employs multiple therapeutic strategies – a more effective treatment option compared to the currently available symptomatic single agent drug therapies being explored.
- Therapy can be performed on an outpatient basis - cheaper costs to patient and health system.
- Less training will be required for the use of minimally-invasive SONS by medical professionals vs. invasive, implantable devices.
- Therapy could possibly apply to other large neurodegenerative disease markets like Parkinson's, Depression, Epilepsy, Multiple Sclerosis, and Autism.